Abstract
Opioid agonists specific for the μ, δ, and κ opioid receptor subtypes were tested for their ability to modulate potassium-evoked release of L-glutamate and dynorphin B-like immunoreactivity from guinea pig hippocampal mossy fiber synaptosomes. The κ opioid agonists U-62,066E and (−) ethylketocyclazocine, but not the μ agonist [D-Ala2,N-MePhe4,Gly5-ol]-enkephalin (DAGO) nor the δ agonist [D-Pen2,5]enkephalin (DPDE), inhibited the potassium-evoked release of L-glutamate and dynorphin B-like immunoreactivity. U-62,066E, but not DAGO or DPDE, also inhibited the potassium-evoked rise in mossy fiber synaptosomal cytosolic Ca2+ levels, indicating a possible mechanism for κ agonist inhibition of transmitter release. DAGO and DPDE were found to be without any effect on cytosolic Ca2+ levels or transmitter release in this preparation. The U-62,066E inhibition of the potassium-evoked rise in synaptosomal cytosolic Ca2+ levels was partially attenuated by the opioid antagonist quadazocine and insensitive to the δ-opioid specific antagonist ICI 174,864 and the μ opioid-preferring antagonists naloxone and naltrexone. Quadazocine also reversed U-62,066E inhibition of the potassium-evoked release of L-glutamate, but not dynorphin B-like immunoreactivity. These results suggest that κ opioid agonists inhibit transmitter release from mossy fiber terminals through both κ opioid and non-κ opioid receptor mediated mechanisms.
Similar content being viewed by others
References
Gall, C. 1988. Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibers. J. Neurosci. 8:1852–1862.
Kanamatsu, T., McGinty, J. F., Mitchell, C. L., and Hong, J. S. 1986. Dynorphin- and enkephalin-like immunoreactivity is altered in limbic-basal ganglia regions of rat brain after repeated electroconvulsive shock. J. Neurosci. 6:644–649.
McGinty, J. F., Henriksen, S. J., Goldstein, A., Terenius, L., and Bloom, F. E. 1983. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchioine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 80:589–593.
McLean, S., Rothman, R. B., Jacobson, A. E., Rice, K. C., and Herkenham, M. 1987. Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster. J. Comp. Neurol. 255:497–510.
Stengaard-Pedersen, K., Fredens, K., and Larsson, L.-I. 1983. Comparative localization of enkephalin and cholecystokinin immunoreactivities and heavy metals in the hippocampus. Brain Res. 273:81–96.
Gannon, R. L., Baty, L. T., and Terrian, D. M. 1989. L(+)-2-Amino-4-phosphonobutyrate inhibits the release of both glutamate and dynorphin from guinea pig but not rat hippocampal mossy fiber synaptosomes. Brain Res. 495:151–155.
Terrian, D. M., Gannon, R. L., and Rea, M. A. 1990. Glutamate is the endogenous amino acid selectively released by rat hippocampal mossy fiber synaptosomes concomitantly with prodynorphin-derived peptides. Neurochem. Res. 15:1–5.
Terrian, D. M., Johnston, D., Claiborne, B. J., Ansah-Yiadom, R., Strittmatter, W. J., and Rea, M. A. 1988. Glutamate and dynorphin release from a subcellular fraction enriched in hippocampal mossy fiber synaptosomes. Brain Res. Bull. 21:343–351.
Kosterlitz, H. W. 1985. Opioid peptides and their receptors. Proc. R. Soc. Lond. B. 225:27–40.
Leslie, F. M. 1987. Methods used for the study of opioid receptors. Pharmac. Rev. 39:197–249.
Caudle, R. M., and Chavkin, C. 1990. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig. J. Pharmacol. Exp. Ther. 252:1361–1369.
Iwama, T., Ishihara, K., Satoh, M., and Takagi, H. 1986. Different effects of dynorphin A on in vitro guinea pig hippocampal CA3 pyramidal cells with various degrees of paired-pulse facilitation. Neurosci. Lett. 63:190–194.
Iwama, T., Ishara, K., Takagi, H., and Satoh, M. 1987. Possible mechanism involved in the inhibitory action of U-50,488H, an opioid κ agonist, on guinea pig hippocampal CA3 pyramidal neurons in vitro. J. Pharmacobio-Dyn. 10:564–570.
Martin, M. R. 1983. Naloxone and long term potentiation of hippocampal CA3 field potentials in vitro. Neuropeptides. 4:45–50.
Chavkin, C., James, I. F., and Goldstein, A. 1982. Dynorphin is a specific endogenous ligand of the κ opioid receptor. Nature. 215:413–415.
Moises, H. C., and Walker, J. M., 1985. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat. Eur. J. Pharm. 108:85–98.
Vonvoigtlander, P. F., Lahti, R. A., and Ludens, J. H. 1983. U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:7–12.
Gannon, R. L., and Terrian, D. M. 1991. U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals. Brain Res. 548:242–247.
Alzheimer, C., and Ten Bruggencate, G. 1990. Nonopoiod actions of the κ-opioid receptor agonists, U 50488H and U 69593, on electrophysiological properties of hippocampal CA3 neuronsin vitro. J. Pharmacol. Exp. Ther. 255:900–905.
Perry, D. C., and Grimes, L. M. 1989. Administration of kainic acid and colchicine alters μ and λ opiate binding in rat hippocampus. Brain Res. 477:100–108.
Grevel, J., and Sadée, W. 1983. An opiate binding site in the rat brain is highly selective for 4,5-epoxymorphinans. Science 221:1198–1201.
Perry, D. C., and Sadée, W. 1986. Autoradiography of λ binding sites in rat brain. Eur. J. Pharm. 129:147–158.
Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:346–356.
Terrian, D. M., Hernandez, P. G., Rea, M. A., and Peters, R. I. 1989. ATP release, adenosine formation, and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes. J. Neurochem. 53:1390–1399.
Graham, L. T. Jr., and Aprison, M. H. 1966. Fluorometric determination of aspartate, glutamate, and λ-aminobutyrate in nerve tissue using enzymic methods. Anal. Biochem. 15:487–497.
Grynkiewicz, G., Poenie, M., and Tsien, R. Y. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440–3448.
Goldstein, A. 1984. Biology and Chemistry of the dynorphin peptides. Pages 95–145,in Udenfriend, S., and Meienhofer, J. (eds.), The Peptides, Vol. 6, Academic Press, New York.
Vonvoigtlander, P. F., and Lewis, R. A. 1988. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. J. Pharmacol. Exp. Ther. 246:259–262.
Magnan, J., Paterson, J., Tavani, A., and Kosterlitz, H. W. 1982. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmied. Arch. Pharmacol. 319:197–205.
Takemori, A. E., Ho, B. Y., Naeseth, J. S., and Portoghese, P. S. 1988. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246:255–258.
Ward, S. J., Pierson, A. K., and Michne, W. F. 1983. Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist WIN 44,441-3. Life Sci. 33 (Suppl.):303–306.
Zukin, R. S., Eghbali, M., Olive, D., Unterwald, E. M., and Tempel, A. 1988. Characterization and visualization of rat and guinea pig brain κ opioid receptors: evidence for κ1 and κ2 opioid receptors. Proc. Natl. Acad. Sci. USA. 85:4061–4065.
Iyengar, S., Kim, H. S., and Wood, P. L. 1986. Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. Life Sci. 39:637–644.
Xiang, J.-Z., Adamson, P., Brammer, M. J., and Campbell, I. C. 1990. the κ-opiate agonist U50488H decreases the entry of45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels. Neuropharm. 29:439–444.
Gross, R. A., and Macdonald, R. L. 1987. Dynorphin A seiectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci. USA. 84:5469–5473.
Terrian, D. M., Damron, D. S., Dorman, R. V., and Gannon, R. L. 1989. Effects of calcium antagonists on the evoked release of dynorphin A(1–8) and availability of intraterminal calcium in rat hippocampal mossy fiber synaptosomes. Neurosci. Lett. 106:322–327.
Terrian, D. M., Dorman, R. V., and Gannon, R. L. 1990. Characterization of the presynaptic calcium channels involved in glutamate exocytosis from rat hippocampal mossy fiber synaptosomes. Neurosci. Lett. 119:211–214.
Houser, C. R., Miyashiro, J. E., Swartz, B. E., Walsh, G. O., Rich, J. R., and Delgado-Escueta, A. V. 1990. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10:267–282.
Represa, A., Robain, O., Tremblay, E., and Ben-Ari, Y. 1989. Hippocampal plasticity in childhood epilepsy. Neurosci. Lett. 99:351–355.
Sutula, T., Cascino, G., Cavazos, J., Parada, I., and Ramirez, L. 1989. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26:321–330.
Ben-Ari, Y., and Represa, A. 1990. Brief seizure episodes induce long-term potentiation and mossy fibre sprouting in the hippocampus. Trends Neurosci. 13:312–318.
Cronin, J., and Dudek, F. E. 1988. Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats. Brain Res. 474:181–184.
Gail, C., Lauterborn, J., Isackson, P., and White, J. 1990. Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 83:371–390.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gannon, R.L., Terrian, D.M. Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes. Neurochem Res 17, 741–747 (1992). https://doi.org/10.1007/BF00969007
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969007